Quest Diagnostics Incorporated · NYSE:DGX
Quest Diagnostics — Investor Day (November 2014)
8 slides from Quest Diagnostics's investor day presentation, Nov 5, 2014
Slide 1: Building Our Clinical Franchises
Building Our Clinical Franchises Cathy Doherty Senior Vice President & Group Executive Clinical Franchise Solutions November 5th, 2014
Slide 2: Safe Harbor Disclosure
| 2 Safe Harbor Disclosure The statements in this presentation which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management’s current
Slide 3: Clinical Franchise, Science & Innovation, Value Creation
| 3 Clinical Franchise Science & Innovation Value Creation
Slide 4: Clinical Franchises Organized by Disease/Health State
| 4 General Health & Wellness Cardiovascular, Metabolic & Endo Infectious Disease/ Immunology Neurology Women’s and Reproductive Health Prescription Drug Monitoring/ Toxicology Cancer Diagnostics Clinical Franchises Organized by Disease/Health State 2 3 4 5 6 1 7 Sports Diagnostics 8
Slide 5: Case Study #1: Prescription Drug Monitoring
| 5 Case Study #1: Prescription Drug Monitoring 2009 2010 2011 2012 2013 Market Size $2 billion annually; growing double digits. Estimated 100M Americans are in pain; 259M painkiller prescriptions written in 2013 Market Need Help physicians manage prescription drug abuse, misuse, and non-use by moni
Slide 6: Prescription Monitoring Program Enables Physicians and Public Health Authorities to Improve Patient Compliance
| 6 Prescription Monitoring Program Enables Physicians and Public Health Authorities to Improve Patient Compliance
Slide 7: Case Study #2: Health & Wellness
| 7 Acquire Summit Health and launch 2nd generation insight driven participant reports Establish Wellness as a critical strategic priority Case Study #2: Health & Wellness Present our first Wellness ROI study at AJHP Launch finger stick solution for worksite clinics & expand biometric capability to
Slide 8: Key Takeaways
| 8 Key Takeaways Clinical Franchises have helped us deliver new solutions Demonstrated ability to grow organically Tapping rapidly growing market segments Expanding pipeline of innovative new solutions awaiting launch